Stock Market News in real time

North American Morning Briefing : Stock Futures -3-

November 15, 2021 at 06:12 am EST

Zynerba Pharmaceuticals Inc (ZYNE) is expected to report $-0.25 for 3Q.

ANALYST RATINGS ACTIONS

BioXcel Therapeutics Cut to Sell From Buy by Goldman Sachs

Catalyst Biosciences Cut to Market Perform From Outperform by Raymond James

National Vision Cut to Neutral From Buy by Goldman Sachs

Prometheus Biosciences Cut to Perform From Outperform by Oppenheimer

TG Therapeutics Cut to Sell From Neutral by Goldman Sachs

This article is a text version of a Wall Street Journal newsletter published earlier today.

(END) Dow Jones Newswires

11-15-21 0612ET

Growth at a reasonable price

Hidehiro Imatsu named president of Goldman Sachs Japan

CAC40: U.S. growth and inflation hold up, Nasdaq -2%.

Battle for 'tech luxury' in China as EVs get smarter - and cheaper

Gucci, Kering's heavy burden

April 25, 2024 at 10:09 am EDT

Honda to set up $11 billion EV production base in Canada

Gold trims gains as US Treasury yields rise after economic data

ICE Canada Morning Comment : Canola Backtracking With Other Veg Oils

BOJ to consider ways to cut its JGB purchases on Friday -Jiji

South African regulatory unit verifying information on BHP bid for Anglo